Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 2
2015 3
2016 4
2017 1
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
Wolf J, Seto T, Han JY, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, Smit EF, Souquet PJ, Vansteenkiste J, Hochmair M, Felip E, Nishio M, Thomas M, Ohashi K, Toyozawa R, Overbeck TR, de Marinis F, Kim TM, Laack E, Robeva A, Le Mouhaer S, Waldron-Lynch M, Sankaran B, Balbin OA, Cui X, Giovannini M, Akimov M, Heist RS; GEOMETRY mono-1 Investigators. Wolf J, et al. N Engl J Med. 2020 Sep 3;383(10):944-957. doi: 10.1056/NEJMoa2002787. N Engl J Med. 2020. PMID: 32877583 Clinical Trial.
[National consensus of diagnosis and treatment of non-small cell lung cancer].
Arrieta O, Guzmán-de Alba E, Alba-López LF, Acosta-Espinoza A, Alatorre-Alexander J, Alexander-Meza JF, Allende-Pérez SR, Alvarado-Aguilar S, Araujo-Navarrete ME, Argote-Greene LM, Aquino-Mendoza CA, Astorga-Ramos AM, Austudillo-de la Vega H, Avilés-Salas A, Barajas-Figueroa LJ, Barroso-Quiroga N, Blake-Cerda M, Cabrera-Galeana PA, Calderillo-Ruíz G, Campos-Parra AD, Cano-Valdez AM, Capdeville-García D, Castillo-Ortega G, Casillas-Suárez C, Castillo-González P, Corona-Cruz JF, Correa-Acevedo ME, Cortez-Ramírez SS, de la Cruz-Vargas JA, de la Garza-Salazar JG, de la Mata-Moya MD, Domínguez-Flores ME, Domínguez-Malagón HR, Domínguez-Parra LM, Domínguez-Peregrina A, Durán-Alcocer J, Enríquez-Aceves MI, Elizondo-Ríos A, Escobedo-Sánchez MD, de Villafranca PE, Flores-Cantisani A, Flores-Gutiérrez JP, Franco-Marina F, Franco-González EE, Franco-Topete RA, Fuentes-de la Peña H, Galicia-Amor S, Gallardo-Rincón D, Gamboa-Domínguez A, García-Andreu J, García-Cuéllar CM, García-Sancho-Figueroa MC, García-Torrentera R, Gerson-Cwilich R, Gómez-González A, Green-Schneeweiss L, Guillén-Núñez Mdel R, Gutiérrez-Velázquez H, Ibarra-Pérez C, Jiménez-Fuentes E, Juárez-Sánchez P, Juárez-Ramiro A, Kell… See abstract for full author list ➔ Arrieta O, et al. Among authors: macedo perez eo. Rev Invest Clin. 2013 Mar;65 Suppl 1:S5-84. Rev Invest Clin. 2013. PMID: 24459776 Spanish.
[National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version].
Barrón-Barrón F, Guzmán-De Alba E, Alatorre-Alexander J, Aldaco-Sarvider F, Bautista-Aragón Y, Blake-Cerda M, Blanco-Vázquez YC, Campos-Gómez S, Corona-Cruz JF, Iñiguez-García MA, Lozano-Ruiz FJ, Maldonado-Magos F, de la Mata-Moya D, Martínez-Barrera LM, Ramos-Prudencio R, Rodríguez-Cid J, Rivera-Rivera S, Trejo-Rosales RR, Aguilar-Ortíz MR, Astudillo-de la Vega H, Barajas-Figueroa LJ, Barroso-Quiroga N, Blanco-Salazar A, Castillo-Ortega G, Domínguez-Parra LM, Enriquez-Aceves MI, Fernández-Orozco A, Figueroa-Morales MA, Green-Schneewiss L, González-Garay JA, González Ramírez-Benfield R, Guadarrama-Orozco A, Guerrero-Ixtlahuac J, Hernández-Barajas D, Hernández-Montes de Oca R, Kelly-García J, Lázaro-León M, Silva-Bravo F, Tellez-Becerra JL, Macedo-Pérez EO, Maza-Ramos G, Mayorga-Butrón JL, Montaño-Velázquez BB, Murillo-Medina K, Narváez-Fernández S, Ochoa-Carrillo FJ, Olivares-Beltrán G, Olivares-Torres C, Ponce de León-Castillo M, Ponce-Viveros MA, Rubio-Gutiérrez JE, Sáenz-Frías JA, Silva-Vivas JA, Santillán-Doherty P, Soto-Ávila JJ, Toledo-Buenrostro V, Vargas-Abrego B, Velasco-Hidalgo L, Zapata-Tarres MM, Quintero-Beuló G, Arrieta O. Barrón-Barrón F, et al. Among authors: macedo perez eo. Salud Publica Mex. 2019 May-Jun;61(3):359-414. doi: 10.21149/9916. Salud Publica Mex. 2019. PMID: 31276353 Spanish.
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
Arrieta O, López-Macías D, Mendoza-García VO, Bacon-Fonseca L, Muñoz-Montaño W, Macedo-Pérez EO, Muñiz-Hernández S, Blake-Cerda M, Corona-Cruz JF. Arrieta O, et al. Among authors: macedo perez eo. Cancer Chemother Pharmacol. 2014 May;73(5):975-82. doi: 10.1007/s00280-014-2429-5. Epub 2014 Apr 1. Cancer Chemother Pharmacol. 2014. PMID: 24687408 Clinical Trial.
Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients.
Arrieta O, Vega-González MT, López-Macías D, Martínez-Hernández JN, Bacon-Fonseca L, Macedo-Pérez EO, Ramírez-Tirado LA, Flores-Estrada D, de la Garza-Salazar J. Arrieta O, et al. Among authors: macedo perez eo. Lung Cancer. 2015 Jun;88(3):282-8. doi: 10.1016/j.lungcan.2015.03.019. Epub 2015 Mar 28. Lung Cancer. 2015. PMID: 25882778 Clinical Trial.
15 results